[Long-term safety of recombinant growth hormone].
Carel
J-C
JC
Service d'endocrinologie diabétologie pédiatrique et Inserm U690, hôpital Robert-Debré, APHP, 48, boulevard Sérurier, 75935 Paris cedex 19, France. carel@rdebre.inserm.fr
Coste
J
J
D016757:Death, Sudden, Cardiac; D004361:Drug Tolerance; D013006:Growth Hormone / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced; D011218:Prader-Willi Syndrome / Q000401:mortality; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012449:Safety
D011994:Recombinant Proteins; D013006:Growth Hormone